Global Companion Diagnostics for Oncology Market Research Report 2026(Status and Outlook)
Companion diagnostic (CDx) is a diagnostic testing kit majorly used by pharmaceutical companies for the development of personalized medicine. CDx tests provide information about the effective use of a corresponding therapeutic product by analyzing the genetic material. With the rise in cancer prevalence, coupled with increasing strategic initiatives, there has been a huge demand for companion diagnostics in the oncology area.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Companion Diagnostics for Oncology market size was estimated at USD 4977.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Companion Diagnostics for Oncology market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Companion Diagnostics for Oncology market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostics for Oncology market.
Global Companion Diagnostics for Oncology Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Agilent Technologies
Illumina
Roche
BioM?rieux
Foundation Medicine
ArcherDX
Qiagen
Thermo Fisher Scientific
Amoy Diagnostics
Abbott
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market Segmentation (by Application)
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Laboratories
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics for Oncology Market
Overview of the regional outlook of the Companion Diagnostics for Oncology Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics for Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics for Oncology, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Companion Diagnostics for Oncology market size was estimated at USD 4977.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Companion Diagnostics for Oncology market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Companion Diagnostics for Oncology market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostics for Oncology market.
Global Companion Diagnostics for Oncology Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Agilent Technologies
Illumina
Roche
BioM?rieux
Foundation Medicine
ArcherDX
Qiagen
Thermo Fisher Scientific
Amoy Diagnostics
Abbott
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market Segmentation (by Application)
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Laboratories
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics for Oncology Market
Overview of the regional outlook of the Companion Diagnostics for Oncology Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics for Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics for Oncology, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Companion Diagnostics for Oncology
1.2 Key Market Segments
1.2.1 Companion Diagnostics for Oncology Segment by Type
1.2.2 Companion Diagnostics for Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics for Oncology Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Companion Diagnostics for Oncology Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Companion Diagnostics for Oncology Product Life Cycle
3.3 Global Companion Diagnostics for Oncology Sales by Manufacturers (2020-2025)
3.4 Global Companion Diagnostics for Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Companion Diagnostics for Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Companion Diagnostics for Oncology Market Competitive Situation and Trends
3.8.1 Companion Diagnostics for Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Companion Diagnostics for Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS FOR ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics for Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Companion Diagnostics for Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostics for Oncology Market
5.7 ESG Ratings of Leading Companies
6 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics for Oncology Sales Market Share by Type (2020-2025)
6.3 Global Companion Diagnostics for Oncology Market Size by Type (2020-2025)
6.4 Global Companion Diagnostics for Oncology Price by Type (2020-2025)
7 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics for Oncology Market Sales by Application (2020-2025)
7.3 Global Companion Diagnostics for Oncology Market Size (M USD) by Application (2020-2025)
7.4 Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2020-2025)
8 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SALES BY REGION
8.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.2 Global Companion Diagnostics for Oncology Sales Market Share by Region
8.2 Global Companion Diagnostics for Oncology Market Size by Region
8.2.1 Global Companion Diagnostics for Oncology Market Size by Region
8.2.2 Global Companion Diagnostics for Oncology Market Size by Region
8.3 North America
8.3.1 North America Companion Diagnostics for Oncology Sales by Country
8.3.2 North America Companion Diagnostics for Oncology Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Companion Diagnostics for Oncology Sales by Country
8.4.2 Europe Companion Diagnostics for Oncology Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Companion Diagnostics for Oncology Sales by Region
8.5.2 Asia Pacific Companion Diagnostics for Oncology Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Companion Diagnostics for Oncology Sales by Country
8.6.2 South America Companion Diagnostics for Oncology Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Companion Diagnostics for Oncology Sales by Region
8.7.2 Middle East and Africa Companion Diagnostics for Oncology Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostics for Oncology by Region(2020-2025)
9.2 Global Companion Diagnostics for Oncology Revenue Market Share by Region (2020-2025)
9.3 Global Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Companion Diagnostics for Oncology Production
9.4.1 North America Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.4.2 North America Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Companion Diagnostics for Oncology Production
9.5.1 Europe Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.5.2 Europe Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Companion Diagnostics for Oncology Production (2020-2025)
9.6.1 Japan Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.6.2 Japan Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Companion Diagnostics for Oncology Production (2020-2025)
9.7.1 China Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.7.2 China Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies Companion Diagnostics for Oncology Product Overview
10.1.3 Agilent Technologies Companion Diagnostics for Oncology Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Illumina
10.2.1 Illumina Basic Information
10.2.2 Illumina Companion Diagnostics for Oncology Product Overview
10.2.3 Illumina Companion Diagnostics for Oncology Product Market Performance
10.2.4 Illumina Business Overview
10.2.5 Illumina SWOT Analysis
10.2.6 Illumina Recent Developments
10.3 Roche
10.3.1 Roche Basic Information
10.3.2 Roche Companion Diagnostics for Oncology Product Overview
10.3.3 Roche Companion Diagnostics for Oncology Product Market Performance
10.3.4 Roche Business Overview
10.3.5 Roche SWOT Analysis
10.3.6 Roche Recent Developments
10.4 BioM?rieux
10.4.1 BioM?rieux Basic Information
10.4.2 BioM?rieux Companion Diagnostics for Oncology Product Overview
10.4.3 BioM?rieux Companion Diagnostics for Oncology Product Market Performance
10.4.4 BioM?rieux Business Overview
10.4.5 BioM?rieux Recent Developments
10.5 Foundation Medicine
10.5.1 Foundation Medicine Basic Information
10.5.2 Foundation Medicine Companion Diagnostics for Oncology Product Overview
10.5.3 Foundation Medicine Companion Diagnostics for Oncology Product Market Performance
10.5.4 Foundation Medicine Business Overview
10.5.5 Foundation Medicine Recent Developments
10.6 ArcherDX
10.6.1 ArcherDX Basic Information
10.6.2 ArcherDX Companion Diagnostics for Oncology Product Overview
10.6.3 ArcherDX Companion Diagnostics for Oncology Product Market Performance
10.6.4 ArcherDX Business Overview
10.6.5 ArcherDX Recent Developments
10.7 Qiagen
10.7.1 Qiagen Basic Information
10.7.2 Qiagen Companion Diagnostics for Oncology Product Overview
10.7.3 Qiagen Companion Diagnostics for Oncology Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Thermo Fisher Scientific
10.8.1 Thermo Fisher Scientific Basic Information
10.8.2 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
10.8.3 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Market Performance
10.8.4 Thermo Fisher Scientific Business Overview
10.8.5 Thermo Fisher Scientific Recent Developments
10.9 Amoy Diagnostics
10.9.1 Amoy Diagnostics Basic Information
10.9.2 Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
10.9.3 Amoy Diagnostics Companion Diagnostics for Oncology Product Market Performance
10.9.4 Amoy Diagnostics Business Overview
10.9.5 Amoy Diagnostics Recent Developments
10.10 Abbott
10.10.1 Abbott Basic Information
10.10.2 Abbott Companion Diagnostics for Oncology Product Overview
10.10.3 Abbott Companion Diagnostics for Oncology Product Market Performance
10.10.4 Abbott Business Overview
10.10.5 Abbott Recent Developments
11 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET FORECAST BY REGION
11.1 Global Companion Diagnostics for Oncology Market Size Forecast
11.2 Global Companion Diagnostics for Oncology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostics for Oncology Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region
11.2.4 South America Companion Diagnostics for Oncology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostics for Oncology by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Companion Diagnostics for Oncology Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Companion Diagnostics for Oncology by Type (2026-2035)
12.1.2 Global Companion Diagnostics for Oncology Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Companion Diagnostics for Oncology by Type (2026-2035)
12.2 Global Companion Diagnostics for Oncology Market Forecast by Application (2026-2035)
12.2.1 Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostics for Oncology Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Companion Diagnostics for Oncology
1.2 Key Market Segments
1.2.1 Companion Diagnostics for Oncology Segment by Type
1.2.2 Companion Diagnostics for Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics for Oncology Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Companion Diagnostics for Oncology Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Companion Diagnostics for Oncology Product Life Cycle
3.3 Global Companion Diagnostics for Oncology Sales by Manufacturers (2020-2025)
3.4 Global Companion Diagnostics for Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Companion Diagnostics for Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Companion Diagnostics for Oncology Market Competitive Situation and Trends
3.8.1 Companion Diagnostics for Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Companion Diagnostics for Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS FOR ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics for Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Companion Diagnostics for Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostics for Oncology Market
5.7 ESG Ratings of Leading Companies
6 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics for Oncology Sales Market Share by Type (2020-2025)
6.3 Global Companion Diagnostics for Oncology Market Size by Type (2020-2025)
6.4 Global Companion Diagnostics for Oncology Price by Type (2020-2025)
7 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics for Oncology Market Sales by Application (2020-2025)
7.3 Global Companion Diagnostics for Oncology Market Size (M USD) by Application (2020-2025)
7.4 Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2020-2025)
8 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET SALES BY REGION
8.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.1 Global Companion Diagnostics for Oncology Sales by Region
8.1.2 Global Companion Diagnostics for Oncology Sales Market Share by Region
8.2 Global Companion Diagnostics for Oncology Market Size by Region
8.2.1 Global Companion Diagnostics for Oncology Market Size by Region
8.2.2 Global Companion Diagnostics for Oncology Market Size by Region
8.3 North America
8.3.1 North America Companion Diagnostics for Oncology Sales by Country
8.3.2 North America Companion Diagnostics for Oncology Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Companion Diagnostics for Oncology Sales by Country
8.4.2 Europe Companion Diagnostics for Oncology Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Companion Diagnostics for Oncology Sales by Region
8.5.2 Asia Pacific Companion Diagnostics for Oncology Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Companion Diagnostics for Oncology Sales by Country
8.6.2 South America Companion Diagnostics for Oncology Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Companion Diagnostics for Oncology Sales by Region
8.7.2 Middle East and Africa Companion Diagnostics for Oncology Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostics for Oncology by Region(2020-2025)
9.2 Global Companion Diagnostics for Oncology Revenue Market Share by Region (2020-2025)
9.3 Global Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Companion Diagnostics for Oncology Production
9.4.1 North America Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.4.2 North America Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Companion Diagnostics for Oncology Production
9.5.1 Europe Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.5.2 Europe Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Companion Diagnostics for Oncology Production (2020-2025)
9.6.1 Japan Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.6.2 Japan Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Companion Diagnostics for Oncology Production (2020-2025)
9.7.1 China Companion Diagnostics for Oncology Production Growth Rate (2020-2025)
9.7.2 China Companion Diagnostics for Oncology Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies Companion Diagnostics for Oncology Product Overview
10.1.3 Agilent Technologies Companion Diagnostics for Oncology Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Illumina
10.2.1 Illumina Basic Information
10.2.2 Illumina Companion Diagnostics for Oncology Product Overview
10.2.3 Illumina Companion Diagnostics for Oncology Product Market Performance
10.2.4 Illumina Business Overview
10.2.5 Illumina SWOT Analysis
10.2.6 Illumina Recent Developments
10.3 Roche
10.3.1 Roche Basic Information
10.3.2 Roche Companion Diagnostics for Oncology Product Overview
10.3.3 Roche Companion Diagnostics for Oncology Product Market Performance
10.3.4 Roche Business Overview
10.3.5 Roche SWOT Analysis
10.3.6 Roche Recent Developments
10.4 BioM?rieux
10.4.1 BioM?rieux Basic Information
10.4.2 BioM?rieux Companion Diagnostics for Oncology Product Overview
10.4.3 BioM?rieux Companion Diagnostics for Oncology Product Market Performance
10.4.4 BioM?rieux Business Overview
10.4.5 BioM?rieux Recent Developments
10.5 Foundation Medicine
10.5.1 Foundation Medicine Basic Information
10.5.2 Foundation Medicine Companion Diagnostics for Oncology Product Overview
10.5.3 Foundation Medicine Companion Diagnostics for Oncology Product Market Performance
10.5.4 Foundation Medicine Business Overview
10.5.5 Foundation Medicine Recent Developments
10.6 ArcherDX
10.6.1 ArcherDX Basic Information
10.6.2 ArcherDX Companion Diagnostics for Oncology Product Overview
10.6.3 ArcherDX Companion Diagnostics for Oncology Product Market Performance
10.6.4 ArcherDX Business Overview
10.6.5 ArcherDX Recent Developments
10.7 Qiagen
10.7.1 Qiagen Basic Information
10.7.2 Qiagen Companion Diagnostics for Oncology Product Overview
10.7.3 Qiagen Companion Diagnostics for Oncology Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Thermo Fisher Scientific
10.8.1 Thermo Fisher Scientific Basic Information
10.8.2 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
10.8.3 Thermo Fisher Scientific Companion Diagnostics for Oncology Product Market Performance
10.8.4 Thermo Fisher Scientific Business Overview
10.8.5 Thermo Fisher Scientific Recent Developments
10.9 Amoy Diagnostics
10.9.1 Amoy Diagnostics Basic Information
10.9.2 Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
10.9.3 Amoy Diagnostics Companion Diagnostics for Oncology Product Market Performance
10.9.4 Amoy Diagnostics Business Overview
10.9.5 Amoy Diagnostics Recent Developments
10.10 Abbott
10.10.1 Abbott Basic Information
10.10.2 Abbott Companion Diagnostics for Oncology Product Overview
10.10.3 Abbott Companion Diagnostics for Oncology Product Market Performance
10.10.4 Abbott Business Overview
10.10.5 Abbott Recent Developments
11 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET FORECAST BY REGION
11.1 Global Companion Diagnostics for Oncology Market Size Forecast
11.2 Global Companion Diagnostics for Oncology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostics for Oncology Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region
11.2.4 South America Companion Diagnostics for Oncology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostics for Oncology by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Companion Diagnostics for Oncology Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Companion Diagnostics for Oncology by Type (2026-2035)
12.1.2 Global Companion Diagnostics for Oncology Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Companion Diagnostics for Oncology by Type (2026-2035)
12.2 Global Companion Diagnostics for Oncology Market Forecast by Application (2026-2035)
12.2.1 Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostics for Oncology Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Companion Diagnostics for Oncology Market Size by Type (M USD)
Table 4. Global Companion Diagnostics for Oncology Market Size by Application
Table 5. Companion Diagnostics for Oncology Market Size Comparison by Region (M USD)
Table 6. Global Companion Diagnostics for Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Companion Diagnostics for Oncology Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Companion Diagnostics for Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics for Oncology as of 2025)
Table 11. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Companion Diagnostics for Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics for Oncology Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Companion Diagnostics for Oncology Sales by Type (K Units)
Table 27. Global Companion Diagnostics for Oncology Market Size by Type (M USD)
Table 28. Global Companion Diagnostics for Oncology Sales (K Units) by Type (2020-2025)
Table 29. Global Companion Diagnostics for Oncology Sales Market Share by Type (2020-2025)
Table 30. Global Companion Diagnostics for Oncology Market Size (M USD) by Type (2020-2025)
Table 31. Global Companion Diagnostics for Oncology Market Share by Type (2020-2025)
Table 32. Global Companion Diagnostics for Oncology Price (USD/Unit) by Type (2020-2025)
Table 33. Global Companion Diagnostics for Oncology Sales (K Units) by Application
Table 34. Global Companion Diagnostics for Oncology Market Size by Application
Table 35. Global Companion Diagnostics for Oncology Sales by Application (2020-2025) & (K Units)
Table 36. Global Companion Diagnostics for Oncology Sales Market Share by Application (2020-2025)
Table 37. Global Companion Diagnostics for Oncology Market Size by Application (2020-2025) & (M USD)
Table 38. Global Companion Diagnostics for Oncology Market Share by Application (2020-2025)
Table 39. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2020-2025)
Table 40. Global Companion Diagnostics for Oncology Sales by Region (2020-2025) & (K Units)
Table 41. Global Companion Diagnostics for Oncology Sales Market Share by Region (2020-2025)
Table 42. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (M USD)
Table 43. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025)
Table 44. North America Companion Diagnostics for Oncology Sales by Country (2020-2025) & (K Units)
Table 45. North America Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Companion Diagnostics for Oncology Sales by Country (2020-2025) & (K Units)
Table 47. Europe Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Companion Diagnostics for Oncology Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (M USD)
Table 50. South America Companion Diagnostics for Oncology Sales by Country (2020-2025) & (K Units)
Table 51. South America Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Companion Diagnostics for Oncology Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (M USD)
Table 54. Global Companion Diagnostics for Oncology Production (K Units) by Region(2020-2025)
Table 55. Global Companion Diagnostics for Oncology Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Companion Diagnostics for Oncology Revenue Market Share by Region (2020-2025)
Table 57. Global Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Agilent Technologies Basic Information
Table 63. Agilent Technologies Companion Diagnostics for Oncology Product Overview
Table 64. Agilent Technologies Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies SWOT Analysis
Table 67. Agilent Technologies Recent Developments
Table 68. Illumina Basic Information
Table 69. Illumina Companion Diagnostics for Oncology Product Overview
Table 70. Illumina Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Illumina Business Overview
Table 72. Illumina SWOT Analysis
Table 73. Illumina Recent Developments
Table 74. Roche Basic Information
Table 75. Roche Companion Diagnostics for Oncology Product Overview
Table 76. Roche Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Roche Business Overview
Table 78. Roche SWOT Analysis
Table 79. Roche Recent Developments
Table 80. BioM?rieux Basic Information
Table 81. BioM?rieux Companion Diagnostics for Oncology Product Overview
Table 82. BioM?rieux Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. BioM?rieux Business Overview
Table 84. BioM?rieux Recent Developments
Table 85. Foundation Medicine Basic Information
Table 86. Foundation Medicine Companion Diagnostics for Oncology Product Overview
Table 87. Foundation Medicine Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Foundation Medicine Business Overview
Table 89. Foundation Medicine Recent Developments
Table 90. ArcherDX Basic Information
Table 91. ArcherDX Companion Diagnostics for Oncology Product Overview
Table 92. ArcherDX Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ArcherDX Business Overview
Table 94. ArcherDX Recent Developments
Table 95. Qiagen Basic Information
Table 96. Qiagen Companion Diagnostics for Oncology Product Overview
Table 97. Qiagen Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Qiagen Business Overview
Table 99. Qiagen Recent Developments
Table 100. Thermo Fisher Scientific Basic Information
Table 101. Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
Table 102. Thermo Fisher Scientific Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Recent Developments
Table 105. Amoy Diagnostics Basic Information
Table 106. Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
Table 107. Amoy Diagnostics Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Amoy Diagnostics Business Overview
Table 109. Amoy Diagnostics Recent Developments
Table 110. Abbott Basic Information
Table 111. Abbott Companion Diagnostics for Oncology Product Overview
Table 112. Abbott Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Abbott Business Overview
Table 114. Abbott Recent Developments
Table 115. Global Companion Diagnostics for Oncology Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Companion Diagnostics for Oncology Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Companion Diagnostics for Oncology Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Companion Diagnostics for Oncology Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Companion Diagnostics for Oncology Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Companion Diagnostics for Oncology Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Companion Diagnostics for Oncology Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Companion Diagnostics for Oncology Market Size by Type (M USD)
Table 4. Global Companion Diagnostics for Oncology Market Size by Application
Table 5. Companion Diagnostics for Oncology Market Size Comparison by Region (M USD)
Table 6. Global Companion Diagnostics for Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Companion Diagnostics for Oncology Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Companion Diagnostics for Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics for Oncology as of 2025)
Table 11. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Companion Diagnostics for Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics for Oncology Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Companion Diagnostics for Oncology Sales by Type (K Units)
Table 27. Global Companion Diagnostics for Oncology Market Size by Type (M USD)
Table 28. Global Companion Diagnostics for Oncology Sales (K Units) by Type (2020-2025)
Table 29. Global Companion Diagnostics for Oncology Sales Market Share by Type (2020-2025)
Table 30. Global Companion Diagnostics for Oncology Market Size (M USD) by Type (2020-2025)
Table 31. Global Companion Diagnostics for Oncology Market Share by Type (2020-2025)
Table 32. Global Companion Diagnostics for Oncology Price (USD/Unit) by Type (2020-2025)
Table 33. Global Companion Diagnostics for Oncology Sales (K Units) by Application
Table 34. Global Companion Diagnostics for Oncology Market Size by Application
Table 35. Global Companion Diagnostics for Oncology Sales by Application (2020-2025) & (K Units)
Table 36. Global Companion Diagnostics for Oncology Sales Market Share by Application (2020-2025)
Table 37. Global Companion Diagnostics for Oncology Market Size by Application (2020-2025) & (M USD)
Table 38. Global Companion Diagnostics for Oncology Market Share by Application (2020-2025)
Table 39. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2020-2025)
Table 40. Global Companion Diagnostics for Oncology Sales by Region (2020-2025) & (K Units)
Table 41. Global Companion Diagnostics for Oncology Sales Market Share by Region (2020-2025)
Table 42. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (M USD)
Table 43. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025)
Table 44. North America Companion Diagnostics for Oncology Sales by Country (2020-2025) & (K Units)
Table 45. North America Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Companion Diagnostics for Oncology Sales by Country (2020-2025) & (K Units)
Table 47. Europe Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Companion Diagnostics for Oncology Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (M USD)
Table 50. South America Companion Diagnostics for Oncology Sales by Country (2020-2025) & (K Units)
Table 51. South America Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Companion Diagnostics for Oncology Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (M USD)
Table 54. Global Companion Diagnostics for Oncology Production (K Units) by Region(2020-2025)
Table 55. Global Companion Diagnostics for Oncology Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Companion Diagnostics for Oncology Revenue Market Share by Region (2020-2025)
Table 57. Global Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Companion Diagnostics for Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Agilent Technologies Basic Information
Table 63. Agilent Technologies Companion Diagnostics for Oncology Product Overview
Table 64. Agilent Technologies Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies SWOT Analysis
Table 67. Agilent Technologies Recent Developments
Table 68. Illumina Basic Information
Table 69. Illumina Companion Diagnostics for Oncology Product Overview
Table 70. Illumina Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Illumina Business Overview
Table 72. Illumina SWOT Analysis
Table 73. Illumina Recent Developments
Table 74. Roche Basic Information
Table 75. Roche Companion Diagnostics for Oncology Product Overview
Table 76. Roche Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Roche Business Overview
Table 78. Roche SWOT Analysis
Table 79. Roche Recent Developments
Table 80. BioM?rieux Basic Information
Table 81. BioM?rieux Companion Diagnostics for Oncology Product Overview
Table 82. BioM?rieux Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. BioM?rieux Business Overview
Table 84. BioM?rieux Recent Developments
Table 85. Foundation Medicine Basic Information
Table 86. Foundation Medicine Companion Diagnostics for Oncology Product Overview
Table 87. Foundation Medicine Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Foundation Medicine Business Overview
Table 89. Foundation Medicine Recent Developments
Table 90. ArcherDX Basic Information
Table 91. ArcherDX Companion Diagnostics for Oncology Product Overview
Table 92. ArcherDX Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ArcherDX Business Overview
Table 94. ArcherDX Recent Developments
Table 95. Qiagen Basic Information
Table 96. Qiagen Companion Diagnostics for Oncology Product Overview
Table 97. Qiagen Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Qiagen Business Overview
Table 99. Qiagen Recent Developments
Table 100. Thermo Fisher Scientific Basic Information
Table 101. Thermo Fisher Scientific Companion Diagnostics for Oncology Product Overview
Table 102. Thermo Fisher Scientific Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Recent Developments
Table 105. Amoy Diagnostics Basic Information
Table 106. Amoy Diagnostics Companion Diagnostics for Oncology Product Overview
Table 107. Amoy Diagnostics Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Amoy Diagnostics Business Overview
Table 109. Amoy Diagnostics Recent Developments
Table 110. Abbott Basic Information
Table 111. Abbott Companion Diagnostics for Oncology Product Overview
Table 112. Abbott Companion Diagnostics for Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Abbott Business Overview
Table 114. Abbott Recent Developments
Table 115. Global Companion Diagnostics for Oncology Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Companion Diagnostics for Oncology Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Companion Diagnostics for Oncology Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Companion Diagnostics for Oncology Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Companion Diagnostics for Oncology Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Companion Diagnostics for Oncology Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Companion Diagnostics for Oncology Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Companion Diagnostics for Oncology Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Companion Diagnostics for Oncology Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Companion Diagnostics for Oncology Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Companion Diagnostics for Oncology Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Companion Diagnostics for Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics for Oncology Market Size (M USD), 2025-2035
Figure 5. Global Companion Diagnostics for Oncology Market Size (M USD) (2020-2035)
Figure 6. Global Companion Diagnostics for Oncology Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics for Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Companion Diagnostics for Oncology Product Life Cycle
Figure 13. Companion Diagnostics for Oncology Sales Share by Manufacturers in 2025
Figure 14. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers in 2025
Figure 15. Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics for Oncology Revenue in 2025
Figure 18. Industry Chain Map of Companion Diagnostics for Oncology
Figure 19. Global Companion Diagnostics for Oncology Market PEST Analysis
Figure 20. Global Companion Diagnostics for Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Companion Diagnostics for Oncology Market Share by Type
Figure 27. Sales Market Share of Companion Diagnostics for Oncology by Type (2020-2025)
Figure 28. Sales Market Share of Companion Diagnostics for Oncology by Type in 2025
Figure 29. Market Share of Companion Diagnostics for Oncology by Type (2020-2025)
Figure 30. Market Share of Companion Diagnostics for Oncology by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Companion Diagnostics for Oncology Market Share by Application
Figure 33. Global Companion Diagnostics for Oncology Sales Market Share by Application (2020-2025)
Figure 34. Global Companion Diagnostics for Oncology Sales Market Share by Application in 2025
Figure 35. Global Companion Diagnostics for Oncology Market Share by Application (2020-2025)
Figure 36. Global Companion Diagnostics for Oncology Market Share by Application in 2025
Figure 37. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2020-2025)
Figure 38. Global Companion Diagnostics for Oncology Sales Market Share by Region (2020-2025)
Figure 39. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025)
Figure 40. North America Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Companion Diagnostics for Oncology Sales Market Share by Country in 2024
Figure 43. North America Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Companion Diagnostics for Oncology Market Size by Country in 2024
Figure 45. U.S. Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Companion Diagnostics for Oncology Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Companion Diagnostics for Oncology Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Companion Diagnostics for Oncology Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Companion Diagnostics for Oncology Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Companion Diagnostics for Oncology Sales Market Share by Country in 2024
Figure 53. Europe Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Companion Diagnostics for Oncology Market Size by Country in 2024
Figure 55. Germany Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Companion Diagnostics for Oncology Sales Market Share by Region in 2024
Figure 67. Asia Pacific Companion Diagnostics for Oncology Market Size by Region in 2024
Figure 68. China Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 79. South America Companion Diagnostics for Oncology Sales Market Share by Country in 2024
Figure 80. South America Companion Diagnostics for Oncology Market Size and Growth Rate (M USD)
Figure 81. South America Companion Diagnostics for Oncology Market Size by Country in 2024
Figure 82. Brazil Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Companion Diagnostics for Oncology Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Companion Diagnostics for Oncology Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Companion Diagnostics for Oncology Market Size by Region in 2024
Figure 92. Saudi Arabia Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Companion Diagnostics for Oncology Production Market Share by Region (2020-2025)
Figure 103. North America Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. China Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Companion Diagnostics for Oncology Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Companion Diagnostics for Oncology Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Companion Diagnostics for Oncology Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Companion Diagnostics for Oncology Market Share Forecast by Type (2026-2035)
Figure 111. Global Companion Diagnostics for Oncology Sales Forecast by Application (2026-2035)
Figure 112. Global Companion Diagnostics for Oncology Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Companion Diagnostics for Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics for Oncology Market Size (M USD), 2025-2035
Figure 5. Global Companion Diagnostics for Oncology Market Size (M USD) (2020-2035)
Figure 6. Global Companion Diagnostics for Oncology Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics for Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Companion Diagnostics for Oncology Product Life Cycle
Figure 13. Companion Diagnostics for Oncology Sales Share by Manufacturers in 2025
Figure 14. Global Companion Diagnostics for Oncology Revenue Share by Manufacturers in 2025
Figure 15. Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Companion Diagnostics for Oncology Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics for Oncology Revenue in 2025
Figure 18. Industry Chain Map of Companion Diagnostics for Oncology
Figure 19. Global Companion Diagnostics for Oncology Market PEST Analysis
Figure 20. Global Companion Diagnostics for Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Companion Diagnostics for Oncology Market Share by Type
Figure 27. Sales Market Share of Companion Diagnostics for Oncology by Type (2020-2025)
Figure 28. Sales Market Share of Companion Diagnostics for Oncology by Type in 2025
Figure 29. Market Share of Companion Diagnostics for Oncology by Type (2020-2025)
Figure 30. Market Share of Companion Diagnostics for Oncology by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Companion Diagnostics for Oncology Market Share by Application
Figure 33. Global Companion Diagnostics for Oncology Sales Market Share by Application (2020-2025)
Figure 34. Global Companion Diagnostics for Oncology Sales Market Share by Application in 2025
Figure 35. Global Companion Diagnostics for Oncology Market Share by Application (2020-2025)
Figure 36. Global Companion Diagnostics for Oncology Market Share by Application in 2025
Figure 37. Global Companion Diagnostics for Oncology Sales Growth Rate by Application (2020-2025)
Figure 38. Global Companion Diagnostics for Oncology Sales Market Share by Region (2020-2025)
Figure 39. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025)
Figure 40. North America Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Companion Diagnostics for Oncology Sales Market Share by Country in 2024
Figure 43. North America Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Companion Diagnostics for Oncology Market Size by Country in 2024
Figure 45. U.S. Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Companion Diagnostics for Oncology Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Companion Diagnostics for Oncology Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Companion Diagnostics for Oncology Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Companion Diagnostics for Oncology Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Companion Diagnostics for Oncology Sales Market Share by Country in 2024
Figure 53. Europe Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Companion Diagnostics for Oncology Market Size by Country in 2024
Figure 55. Germany Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Companion Diagnostics for Oncology Sales Market Share by Region in 2024
Figure 67. Asia Pacific Companion Diagnostics for Oncology Market Size by Region in 2024
Figure 68. China Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 79. South America Companion Diagnostics for Oncology Sales Market Share by Country in 2024
Figure 80. South America Companion Diagnostics for Oncology Market Size and Growth Rate (M USD)
Figure 81. South America Companion Diagnostics for Oncology Market Size by Country in 2024
Figure 82. Brazil Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Companion Diagnostics for Oncology Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Companion Diagnostics for Oncology Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Companion Diagnostics for Oncology Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Companion Diagnostics for Oncology Market Size by Region in 2024
Figure 92. Saudi Arabia Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Companion Diagnostics for Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Companion Diagnostics for Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Companion Diagnostics for Oncology Production Market Share by Region (2020-2025)
Figure 103. North America Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. China Companion Diagnostics for Oncology Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Companion Diagnostics for Oncology Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Companion Diagnostics for Oncology Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Companion Diagnostics for Oncology Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Companion Diagnostics for Oncology Market Share Forecast by Type (2026-2035)
Figure 111. Global Companion Diagnostics for Oncology Sales Forecast by Application (2026-2035)
Figure 112. Global Companion Diagnostics for Oncology Market Share Forecast by Application (2026-2035)
